<p><strong>Behcet's Disease Overview</strong></p>
<p>According to the American Behcet&rsquo;s Disease Association (ABDA) and National Organization for Rare Disorders (NORD), Behcet&rsquo;s syndrome/Behcet&rsquo;s disease (BD) is a rare multisystem inflammatory disorder characterized by ulcers affecting the mouth and genitals, various skin lesions, and abnormalities affecting the eyes. In 1937, Turkish dermatologist Hulusi Behcet called attention to the association of oral and genital ulcerations with hypopyon-uveitis. Behcet&rsquo;s syndrome has become associated with several additional clinical manifestations, each attributed to an underlying vasculitis affecting vessels of all sizes.</p>
<h2><strong><a href="https://www.delveinsight.com/report-store/behcets-disease-epidemiology-forecast"><span style="text-decoration: underline;">Behcet's Disease Epidemiology</span></a> Segmentation in the 7MM</strong></h2>
<ul>
<li>Diagnosed prevalent cases of Behcet's Disease</li>
<li>Diagnosed cases of Behcet&rsquo;s syndrome based on the age of onset.</li>
<li>Diagnosed cases of Behcet&rsquo;s syndrome based on the clinical manifestations</li>
</ul>
<h3><strong>Behcet's Disease Epidemiological Insights Observed in the 7MM (2021)</strong></h3>
<p>The total prevalent cases of Behcet's Disease in the 7MM was approximately <strong>69,000 in the year 2021</strong>.</p>
<h2><strong><a href="https://www.delveinsight.com/report-store/behcets-disease-market"><span style="text-decoration: underline;">Behcet's Disease Market Insight</span></a>&nbsp;</strong></h2>
<p>The market size of Behcet's Disease in the 7MM is approximately <strong>~USD 95 Million in the year 2021.</strong></p>
<h3><strong>Behcet's Disease Market Strengths</strong></h3>
<ul>
<li>Studies suggest that Behcet&rsquo;s syndrome shares common features with autoimmune and inflammatory disorders, thus leading to the detection of the main mediators involved in the pathomechanism of Behcet&rsquo;s syndrome.</li>
</ul>
<h3><strong>Behcet's Disease&nbsp; Market Opportunities</strong></h3>
<ul>
<li>There is an attractive market for therapies with a primary goal of treatment to rapidly suppress and prevent new inflammatory attacks to avoid irreversible organ damage, especially in the early, active stages of Behcet&rsquo;s syndrome.</li>
</ul>
<h3><a href="https://www.delveinsight.com/report-store/behcets-disease-pipeline-insight"><span style="text-decoration: underline;"><strong>Behcet's Disease Emerging drugs</strong></span></a></h3>
<p>The emerging drugs in the Behcet's Disease market are</p>
<ul>
<li>OTEZLA</li>
</ul>
<h3><strong>Behcet's Disease key players</strong></h3>
<p>The key players working in the&nbsp; Behcet's Disease market are</p>
<ul>
<li>Amgen</li>
</ul>

Behcet's Disease Market

Behcet's Disease Market Infographics

Behcet's Disease Symptoms, Treatment, epidemiology, companies, drugs, infographic is a short guide to understand the problem and market landscape